Axa’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,300
| Closed | -$307K | – | 1266 |
|
|
2021
Q4 | $307K | Sell |
3,300
-2,400
| -42% | -$158K | ﹤0.01% | 1084 |
|
|
2021
Q3 | $339K | Buy |
5,700
+300
| +6% | +$17.7K | ﹤0.01% | 1122 |
|
|
2021
Q2 | $368K | Buy |
+5,400
| New | +$352K | ﹤0.01% | 1143 |
|
|
2021
Q1 | – | Sell |
-129,228
| Closed | -$9.93M | – | 1374 |
|
|
2020
Q4 | $9.93M | Sell |
129,228
-64,162
| -33% | -$4.81M | 0.03% | 525 |
|
|
2020
Q3 | $14.5M | Sell |
193,390
-47,858
| -20% | -$3.19M | 0.05% | 357 |
|
|
2020
Q2 | $15.2M | Buy |
241,248
+93,461
| +63% | +$5.14M | 0.06% | 335 |
|
|
2020
Q1 | $6.21M | Sell |
147,787
-68,048
| -32% | -$3.12M | 0.03% | 469 |
|
|
2019
Q4 | $9.8M | Buy |
215,835
+4,984
| +2% | +$236K | 0.04% | 457 |
|
|
2019
Q3 | $9.65M | Buy |
210,851
+7,201
| +4% | +$405K | 0.04% | 485 |
|
|
2019
Q2 | $11.9M | Buy |
203,650
+4,088
| +2% | +$211K | 0.05% | 424 |
|
|
2019
Q1 | $8.95M | Buy |
+199,562
| New | +$9.15M | 0.04% | 481 |
|
|
2017
Q3 | – | Sell |
-56,870
| Closed | -$959K | – | 1382 |
|
|
2017
Q2 | $959K | Hold |
56,870
| – | – | ﹤0.01% | 937 |
|
|
2017
Q1 | $830K | Buy |
56,870
+53,130
| +1,421% | +$787K | ﹤0.01% | 969 |
|
|
2016
Q4 | $53K | Buy |
+3,740
| New | +$57.9K | ﹤0.01% | 1234 |
|
|
2013
Q4 | – | Sell |
-4,488
| Closed | -$237K | – | 1435 |
|
|
2013
Q3 | $237K | Buy |
4,488
+904
| +25% | +$60.7K | ﹤0.01% | 1117 |
|
|
2013
Q2 | $276K | Buy |
+3,584
| New | +$293K | ﹤0.01% | 1069 |
|
Axa's ARNA Position: Q1 2022 in Review
Axa sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,300 shares — an estimated $307K sold.
Axa first reported a position in ARNA in Q2 2013 and held it in 16 quarters. The position peaked at $15.2M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Axa reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Axa sold 3,300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $307K.
- Axa first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 16 quarters.
- Axa's Arena Pharmaceuticals Inc position peaked at $15.2M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.